Description

(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate is a high-purity advanced pharmaceutical intermediate, specifically a cephalosporin derivative. This compound is critical for the synthesis of next-generation broad-spectrum antibiotics, offering enhanced stability against β-lactamases. It is primarily required by pharmaceutical R&D laboratories and API manufacturers focused on developing innovative anti-infective therapies.

Application

• Active Pharmaceutical Ingredient (API) Synthesis: Key intermediate in the production of advanced cephalosporin antibiotics.
• Pharmaceutical Research & Development: Used in medicinal chemistry for the design and synthesis of novel antibacterial agents.
• Process Chemistry & Scale-Up: Serves as a critical building block for process optimization and pilot-scale manufacturing.
• Reference Standard: Employed as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.
• Antibacterial Mechanism Studies: Utilized in biochemical research to study drug-target interactions and resistance mechanisms.

Basic Information

Product Name	(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
CAS No.	97164-55-1
Molecular Formula	C23H24N6O6S2
Molecular Weight	544.60 g/mol
Synonyms	CPD 1-cyclopenta[b]pyridinium cephalosporin derivative; Cephalosporin intermediate 97164-55-1; (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; 1-Cyclopentapyridiniummethyl cephalosporin; Antibacterial intermediate 97164-55-1
EINECS	Contact for details

Quality Control

Our (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing to ensure compliance with pharmaceutical-grade specifications. Comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided to guarantee traceability and batch-to-batch consistency for your critical R&D and manufacturing processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.